Biogenea Pharmaceuticals (TM) focuses on the collection, processing, cryopreservation and cGMP (according to Good Manufacturing Practice) production - for solely autologous use - of cellular therapies from blood (bone marrow, peripheral blood, cord blood) or blood compounds for human use to treat degenerative conditions.  Cellgenea is the cord blood banking division of Biogenea.


Biogenea-Cellgenea is a founding member of the Association of Hellenic Cord Blood Banks, EETOA.